PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1635098
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1635098
NGS Sample Preparation Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)
The global next-generation sequencing (NGS) sample preparation market is projected to grow from $2,375.0 million in 2024 to $5,592.8 million by 2030, reflecting a compound annual growth rate (CAGR) of 15.5% during the forecast period.
This growth is primarily driven by technological advancements in NGS platforms, the rising prevalence of genetic disorders, and an increasing demand for direct-to-consumer genetic testing. Additionally, the surging incidence of infectious diseases further enhances market expansion.
Key Insights
The consumables category holds the largest revenue share, accounting for 55% of the market in 2024. This is attributed to the increasing demand for testing and related components in DNA, RNA, and whole-genome sequencing.
The library preparation segment leads the workflow category, expected to maintain its dominance during the forecast period. This is due to the critical role of library preparation in ensuring accurate and efficient sequencing results.
Oncology remains a significant usage area for NGS sample preparation, with applications in cancer diagnosis, treatment selection, and monitoring. The increasing prevalence of cancer globally drives the demand for NGS technologies in oncology.
North America holds the largest share of the NGS sample preparation market, attributed to the high adoption rate of sequencing technologies and substantial investments in research and development. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth, driven by an increase in NGS-based research and clinical applications, along with favorable government and private initiatives supporting the development and adoption of NGS technologies.
The market is characterized by a consolidated landscape, with key players focusing on strategic partnerships, mergers, and acquisitions to enhance their product portfolios and expand their market presence. For instance, in March 2021, Integrated DNA Technologies Inc. acquired Swift Biosciences Inc. to expand its library preparation and enrichment products portfolio.
Technological advancements, such as the development of automated workstations, are enhancing the efficiency and accuracy of NGS sample preparation. Automated systems can prepare up to 10 times more samples than manual workflows, meeting the growing demand for high-throughput sequencing.
The increasing prevalence of infectious diseases has highlighted the importance of NGS in pathogen detection and surveillance. NGS technologies enable comprehensive analysis of infectious agents, supporting public health initiatives and outbreak management.
Table of Contents
Chapter 1. Research Background
- 1.1 Research Objectives
- 1.2 Market Definition
- 1.3 Analysis Period
- 1.4 Market Data Reporting Unit
- 1.4.1 Value
- 1.5 Market Size Breakdown by Segment
- 1.5.1 Market Segmentation by Product Type
- 1.5.2 Market Segmentation by Application
- 1.5.3 Market Segmentation by End User
- 1.5.4 Market Segmentation by Usage Area
- 1.5.5 Market Segmentation by Region
- 1.6 Key Stakeholders
Chapter 2. Research Methodology
- 2.1 Secondary Research
- 2.1.1 Paid
- 2.1.2 Unpaid
- 2.1.3 P&S Intelligence Database
- 2.2 Primary Research
- 2.2.1 Breakdown of Primary Research, by Region
- 2.2.2 Breakdown of Primary Research, by Industry Participant
- 2.2.3 Breakdown of Primary Research, by Designation
- 2.2.4 Breakdown of Primary Research, by Company Type
- 2.3 Market Size Estimation
- 2.4 Data Triangulation
- 2.5 Currency Conversion Rates
- 2.6 Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
- 5.1 Expanding Scope of DNA Sequencing
- 5.2 NGS in Clinical Oncology to Advance Personalized Treatment of Cancer
- 5.3 Burden of Cancer
Chapter 6. Definition of Market Segments
- 6.1 By Product Type
- 6.1.1 Consumables
- 6.1.1.1 Library preparation kits
- 6.1.1.2 Sample purification kits
- 6.1.1.3 Sample extraction and isolation kits
- 6.1.1.4 Target enrichment
- 6.1.1.5 Cleanup and selection kits
- 6.1.1.6 Microbiome DNA enrichment
- 6.1.1.7 Others
- 6.1.2 Standalone Automated Instruments
- 6.1.2.1 Fragment analyzers
- 6.1.2.2 Nucleic acid extraction/isolation systems
- 6.1.2.3 DNA selection instruments
- 6.1.2.4 DNA/RNA shearing instruments
- 6.1.2.5 Template preparation instruments
- 6.1.2.6 Ultrasonicators/sonicators
- 6.1.1 Consumables
- 6.2 By Application
- 6.2.1 DNA Sequencing
- 6.2.2 Whole Genome Sequencing
- 6.2.3 RNA Sequencing
- 6.2.4 Methylation Sequencing
- 6.2.5 Others
- 6.3 By End User
- 6.3.1 Hospitals and Clinics
- 6.3.2 Academic and Research Institutes
- 6.3.3 Pharmaceutical and Biotechnology Companies
- 6.3.4 Other End Users
- 6.4 By Usage Area
- 6.4.1 Oncology
- 6.4.2 NIPT
- 6.4.3 Drug Discovery
- 6.4.4 Microbiology
- 6.4.5 Infectious Diseases
- 6.4.6 Germline Disease Risk Evaluation
- 6.4.7 Applied Markets
Chapter 7. Industry Outlook
- 7.1 Global NGS Sample Preparation Market Dynamics
- 7.1.1 Trends
- 7.1.1.1 Partnerships are key to strengthening global health systems
- 7.1.1.2 Customized automated NGS sample preparation platforms are preferred
- 7.1.2 Drivers
- 7.1.2.1 Emerging technologies empowering NGS of DNA
- 7.1.2.2 Massive growth in the life sciences and healthcare industries
- 7.1.3 Impact Analysis of Drivers on Market Forecast
- 7.1.4 Restraints
- 7.1.4.1 Stringent regulatory standards
- 7.1.4.2 High costs of NGS sample preparation instruments
- 7.1.5 Impact Analysis of Restraints on Market Forecast
- 7.1.1 Trends
- 7.2 Global Targeted DNA Sequencing Market Dynamics
- 7.2.1 Drivers
- 7.2.1.1 Increasing research on NGS and its applications
- 7.2.1.2 Launch of advanced targeted DNA/RNA sequencing products
- 7.2.1 Drivers
- 7.3 U.S. Targeted DNA Sequencing Market Dynamics
- 7.3.1 Drivers
- 7.3.1.1 Rising demand for personalized medicine pharmacotherapy
- 7.3.1.2 Grants from government bodies for targeted sequencing studies
- 7.3.1 Drivers
- 7.4 Global Targeted Methylation Sequencing Market Dynamics
- 7.4.1 Drivers
- 7.4.1.1 Increasing usage of biomarkers for early cancer detection and prognosis
- 7.4.1.2 Increasing Rising usage of targeted DNA methylation sequencing in epigenetic drug discovery
- 7.4.1 Drivers
- 7.5 U.S. Targeted Methylation Sequencing Market Dynamics
- 7.5.1 Drivers
- 7.5.1.1 Proliferating research in diagnostics
- 7.5.1 Drivers
- 7.6 Impact of Covid-19
- 7.7 Porter's Five Forces Analysis
- 7.7.1 Bargaining Power of Buyers
- 7.7.2 Bargaining Power of Suppliers
- 7.7.3 Intensity of Rivalry
- 7.7.4 Threat of New Entrants
- 7.7.5 Threat of Substitutes
Chapter 8. Global Market Size and Forecast
- 8.1 Overview
- 8.2 Market Revenue, by Product Type (2019-2030)
- 8.2.1 Consumables Market, by Type
- 8.2.2 Standalone Automated Instruments Market, by Type
- 8.3 Market Revenue, by Application (2019-2030)
- 8.4 Market Revenue, by End User (2019-2030)
- 8.5 Market Revenue, by Usage Area (2019-2030)
- 8.6 Market Revenue, by Region (2019-2030)
Chapter 9. North America Market Size and Forecast
- 9.1 Overview
- 9.2 Market Revenue, by Product Type (2019-2030)
- 9.2.1 Consumables Market, by Type
- 9.2.2 Standalone Automated Instruments Market, by Type
- 9.3 Market Revenue, by Application (2019-2030)
- 9.4 Market Revenue, by End User (2019-2030)
- 9.5 Market Revenue, by Usage Area (2019-2030)
- 9.6 Market Revenue, by Country (2019-2030)
Chapter 10. Europe Market Size and Forecast
- 10.1 Overview
- 10.2 Market Revenue, by Product Type (2019-2030)
- 10.2.1 Consumables Market, by Type
- 10.2.2 Standalone Automated Instruments Market, by Type
- 10.3 Market Revenue, by Application (2019-2030)
- 10.4 Market Revenue, by End User (2019-2030)
- 10.5 Market Revenue, by Usage Area (2019-2030)
- 10.6 Market Revenue, by Country (2019-2030)
Chapter 11. APAC Market Size and Forecast
- 11.1 Overview
- 11.2 Market Revenue, by Product Type (2019-2030)
- 11.2.1 Consumables Market, by Type
- 11.2.2 Standalone Automated Instruments Market, by Type
- 11.3 Market Revenue, by Application (2019-2030)
- 11.4 Market Revenue, by End User (2019-2030)
- 11.5 Market Revenue, by Usage Area (2019-2030)
- 11.6 Market Revenue, by Country (2019-2030)
Chapter 12. LATAM Market Size and Forecast
- 12.1 Overview
- 12.2 Market Revenue, by Product Type (2019-2030)
- 12.2.1 Consumables Market, by Type
- 12.2.2 Standalone Automated Instruments Market, by Type
- 12.3 Market Revenue, by Application (2019-2030)
- 12.4 Market Revenue, by End User (2019-2030)
- 12.5 Market Revenue, by Usage Area (2019-2030)
- 12.6 Market Revenue, by Country (2019-2030)
Chapter 13. MEA Market Size and Forecast
- 13.1 Overview
- 13.2 Market Revenue, by Product Type (2019-2030)
- 13.2.1 Consumables Market, by Type
- 13.2.2 Standalone Automated Instruments Market, by Type
- 13.3 Market Revenue, by Application (2019-2030)
- 13.4 Market Revenue, by End User (2019-2030)
- 13.5 Market Revenue, by Usage Area (2019-2030)
- 13.6 Market Revenue, by Country (2019-2030)
Chapter 14. Competitive Landscape
- 14.1 Key Players
- 14.1.1 Illumina Inc.
- 14.1.2 Agilent Technologies Inc.
- 14.1.3 Thermo Fisher Scientific Inc.
- 14.1.4 ArcherDX Inc.
- 14.1.5 Twist Bioscience Corporation
- 14.1.6 Integrated DNA Technologies Inc.
- 14.1.7 Swift Biosciences Inc.
- 14.1.8 F. Hoffmann-La Roche Ltd.
- 14.2 Recent Strategic Developments of Key Players
- 14.2.1 Partnerships & Collaborations
- 14.2.2 Product Launches
- 14.2.3 Mergers & Acquisitions
- 14.2.4 Other Developments
Chapter 15. Company Profiles
- 15.1 Illumina Inc.
- 15.1.1 Business Overview
- 15.1.2 Product and Service Offerings
- 15.1.3 Key Financial Summary
- 15.2 Thermo Fisher Scientific Inc.
- 15.2.1 Business Overview
- 15.2.2 Product and Service Offerings
- 15.2.3 Key Financial Summary
- 15.3 F. Hoffmann-La Roche Ltd.
- 15.3.1 Business Overview
- 15.3.2 Product and Service Offerings
- 15.3.3 Key Financial Summary
- 15.4 ArcherDX Inc.
- 15.4.1 Business Overview
- 15.4.2 Product and Service Offerings
- 15.5 Pacific Biosciences of California Inc.
- 15.5.1 Business Overview
- 15.5.2 Product and Service Offerings
- 15.5.3 Key Financial Summary
- 15.6 Integrated DNA Technologies Inc.
- 15.6.1 Business Overview
- 15.6.2 Product and Service Offerings
- 15.7 Becton, Dickinson and Company
- 15.7.1 Business Overview
- 15.7.2 Product and Service Offerings
- 15.7.3 Key Financial Summary
- 15.8 Twist Bioscience Corporation
- 15.8.1 Business Overview
- 15.8.2 Product and Service Offerings
- 15.8.3 Key Financial Summary
- 15.9 QIAGEN N.V.
- 15.9.1 Business Overview
- 15.9.2 Product and Service Offerings
- 15.9.3 Key Financial Summary
- 15.10 Beckman Coulter Inc.
- 15.10.1 Business Overview
- 15.10.2 Product and Service Offerings
- 15.11 Agilent Technologies Inc.
- 15.11.1 Business Overview
- 15.11.2 Product and Service Offerings
- 15.11.3 Key Financial Summary
- 15.12 New England Biolabs Inc.
- 15.12.1 Business Overview
- 15.12.2 Product and Service Offerings
- 15.13 Danaher Corporation
- 15.13.1 Business Overview
- 15.13.2 Product and Service Offerings
- 15.14 Oxford Nanopore Technologies plc
- 15.14.1 Business Overview
- 15.14.2 Product and Service Offerings
- 15.15 Bio-Rad Laboratories Inc.
- 15.15.1 Business Overview
- 15.15.2 Product and Service Offerings
Chapter 16. Appendix
- 16.1 Sources and References
- 16.2 Related Reports
